Feedback / Questions
retatrutide (LY3437943) - Eli Lilly
Retatrutide: Primary completion and completion of P3 TRIUMPH-6 trial (NCT06859268) for obesity in Apr 2028
(Eli Lilly)
-
May 1, 2025 -
Q1 2025 Results
Trial completion date • Trial primary completion date
•
Obesity
https://investor.lilly.com/static-files/761fadb8-b911-46d5-85b3-8bac4e054d73
May 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious